Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5520)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 6, 2023 (publication date) through Oct 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Peng XD, You ZY, He LX, Deng Q. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature. World J Clin Cases 2023; 11(22): 5296-5302 [PMID: 37621601 DOI: 10.12998/wjcc.v11.i22.5296] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Peng XD, You ZY, He LX, Deng Q. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature. World J Clin Cases 2023; 11(22): 5296-5302 [PMID: 37621601 DOI: 10.12998/wjcc.v11.i22.5296] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i22/5296.htm |
| Number | Citing Articles |
| 1 |
Mitchell Emmers, Danielle de Graaf-Wuite, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen. Usage of immune checkpoint blockade in peritoneal mesothelioma: a systematic review of the literature. BMJ Connections Oncology 2025; 2(1): e000039 doi: 10.1136/bmjconc-2025-000039
|
| 2 |
Cisplatin/pemetrexed/zimberelimab. Reactions Weekly 2023; 1976(1): 107 doi: 10.1007/s40278-023-46836-y
|